Scholarlink

<p>Urothelial carcinoma (UC) with basal/squamous (Ba/Sq) differentiation is an aggressive subtype associated with chemoresistance and poor prognosis. However, reliable biomarkers for its diagnosis remain limited, and current evaluation largely relies on morphology and p63 immunostaining, which lacks specificity. Using high-resolution spatial transcriptomics, we characterized the molecular continuum underlying Ba/Sq differentiation within UC and validated the findings by immunohistochemistry (IHC) in independent Ba/Sq UC and pure UC cohorts. Functional assays were performed in squamous carcinoma cell lines to assess the role of Galectin-7, a transcriptional target of p63, in cellular proliferation. Spatial analysis revealed a stromal–epithelial signaling axis driving Ba/Sq differentiation within UC, with NGFR-positive basal-like cells inducing Galectin-7 expression during early squamous commitment. Galectin-7 was absent in UC regions but strongly expressed in Ba/Sq-differentiated tumor nests. Its knockdown suppressed squamous carcinoma cell proliferation, supporting a functional role in tumor survival. Immunohistochemical analysis confirmed markedly higher specificity of Galectin-7 (92.2%) compared with p63 (12.5%), while maintaining high sensitivity (89.3% vs. 100%). Galectin-7 positivity was also associated with poorer progression-free survival, indicating its dual diagnostic and prognostic value. This study proposes a molecular and spatial framework for Ba/Sq differentiation within UC and identifies Galectin-7 as a specific diagnostic and prognostic marker, offering potential as a therapeutic target in Ba/Sq UC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Spatial transcriptomics of urothelial carcinoma with basal/squamous differentiation identifies Galectin-7 as a specific marker of squamous lineage commitment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月31日

查看全文
  • Shunsuke Haga,
  • Ryuta Watanabe,
  • Mie Kurata,
  • Noriyoshi Miura,
  • Shuang Liu,
  • Tadahiko Kikugawa,
  • Riko Kitazawa,
  • Masaki Mogi,
  • Takashi Saika

摘要

Urothelial carcinoma (UC) with basal/squamous (Ba/Sq) differentiation is an aggressive subtype associated with chemoresistance and poor prognosis. However, reliable biomarkers for its diagnosis remain limited, and current evaluation largely relies on morphology and p63 immunostaining, which lacks specificity. Using high-resolution spatial transcriptomics, we characterized the molecular continuum underlying Ba/Sq differentiation within UC and validated the findings by immunohistochemistry (IHC) in independent Ba/Sq UC and pure UC cohorts. Functional assays were performed in squamous carcinoma cell lines to assess the role of Galectin-7, a transcriptional target of p63, in cellular proliferation. Spatial analysis revealed a stromal–epithelial signaling axis driving Ba/Sq differentiation within UC, with NGFR-positive basal-like cells inducing Galectin-7 expression during early squamous commitment. Galectin-7 was absent in UC regions but strongly expressed in Ba/Sq-differentiated tumor nests. Its knockdown suppressed squamous carcinoma cell proliferation, supporting a functional role in tumor survival. Immunohistochemical analysis confirmed markedly higher specificity of Galectin-7 (92.2%) compared with p63 (12.5%), while maintaining high sensitivity (89.3% vs. 100%). Galectin-7 positivity was also associated with poorer progression-free survival, indicating its dual diagnostic and prognostic value. This study proposes a molecular and spatial framework for Ba/Sq differentiation within UC and identifies Galectin-7 as a specific diagnostic and prognostic marker, offering potential as a therapeutic target in Ba/Sq UC.